Literature DB >> 15939804

Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP.

Andreas Luchner1, Christian Hengstenberg, Hannelore Löwel, Günter A J Riegger, Heribert Schunkert, Stephan Holmer.   

Abstract

Brain natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP) are markers of heart failure. Although renal dysfunction may increase plasma concentrations, the magnitude of this effect has not been assessed in a head-to-head comparison between the clinically approved tests. We assessed the effect of compensated renal dysfunction on BNP (Triage BNP; Biosite) and NT-proBNP (elecsys proBNP; Roche) in 469 randomly selected stable outpatients after myocardial infarction (MI; Monitoring Trends and Determinants in Cardiovascular Diseases [MONICA] register Augsburg) who were characterized with respect to renal function (glomerular filtration rate [GFR]; Cockroft method) and left ventricular (LV) ejection fraction (EF) and mass (2D echocardiography). BNP and NT-proBNP were elevated in MI patients with LV dysfunction (LVD; EF <35%) compared with MI patients with preserved EF ( >45%; BNP 139+/-27 pg/mL versus 75+/-6; NT-proBNP 816+/-237 pg/mL versus 243+/-20; both P <0.03). Among all MI patients, the prevalence of renal dysfunction (GFR <85 mL/min) was 24%. BNP and NT-proBNP were significantly elevated in MI patients with renal dysfunction (BNP 132+/-17 pg/mL versus 68+/-4 without renal dysfunction; NT-proBNP 535+/-80 pg/mL versus 232+/-19; both P <0.05), and both markers were correlated with GFR in univariate and multivariate analyses (all P <0.01). When binary cut-off values were stratified according to the absence or presence of renal dysfunction (BNP 75 pg/mL and 125 pg/mL, respectively; NT-proBNP 100 pg/mL and 350 pg/mL, respectively), the predictive power of both markers for the detection of LVD increased substantially. BNP and NT-proBNP are almost similarly influenced by mild-to-moderate renal dysfunction. Renal dysfunction is a potential cause of elevated marker concentrations in the absence of LVD, and cut-off concentrations should be stratified according to renal function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15939804     DOI: 10.1161/01.HYP.0000170140.36633.8f

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  40 in total

1.  Correlation between NT proBNP and left ventricular ejection fraction in elderly patients presenting to emergency department with dyspnoea.

Authors:  Amulya C Belagavi; Medha Rao; Aslam Y Pillai; U S Srihari
Journal:  Indian Heart J       Date:  2012 May-Jun

2.  Inflammation increases NT-proBNP and the NT-proBNP/BNP ratio.

Authors:  Juliana Jensen; Li-Ping Ma; Michael L X Fu; David Svaninger; Per-Arne Lundberg; Ola Hammarsten
Journal:  Clin Res Cardiol       Date:  2010-03-13       Impact factor: 5.460

Review 3.  Early management of patients with acute heart failure: state of the art and future directions. A consensus document from the society for academic emergency medicine/heart failure society of America acute heart failure working group.

Authors:  Sean Collins; Alan B Storrow; Nancy M Albert; Javed Butler; Justin Ezekowitz; G Michael Felker; Gregory J Fermann; Gregg C Fonarow; Michael M Givertz; Brian Hiestand; Judd E Hollander; David E Lanfear; Phillip D Levy; Peter S Pang; W Frank Peacock; Douglas B Sawyer; John R Teerlink; Daniel J Lenihan
Journal:  J Card Fail       Date:  2014-07-18       Impact factor: 5.712

4.  Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study.

Authors:  Meyeon Park; Eric Vittinghoff; Michael G Shlipak; Rakesh Mishra; Mary Whooley; Nisha Bansal
Journal:  Am Heart J       Date:  2014-10-14       Impact factor: 4.749

5.  Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy.

Authors:  Donald E Kohan; Yili Pritchett; Mark Molitch; Shihua Wen; Tushar Garimella; Paul Audhya; Dennis L Andress
Journal:  J Am Soc Nephrol       Date:  2011-03-03       Impact factor: 10.121

6.  Are levels of NT-proBNP and SDMA useful to determine diastolic dysfunction in chronic kidney disease and renal transplant patients?

Authors:  Lidija Memon; Vesna Spasojevic-Kalimanovska; Natasa Bogavac Stanojevic; Jelena Kotur-Stevuljevic; Sanja Simic-Ogrizovic; Vojislav Giga; Violeta Dopsaj; Zorana Jelic-Ivanovic; Slavica Spasic
Journal:  J Clin Lab Anal       Date:  2013-11       Impact factor: 2.352

7.  B-type natriuretic peptides strongly predict mortality in patients who are treated with long-term dialysis.

Authors:  Matthew A Roberts; Piyush M Srivastava; Neil Macmillan; David L Hare; Sujiva Ratnaike; Ken Sikaris; Francesco L Ierino
Journal:  Clin J Am Soc Nephrol       Date:  2008-05-01       Impact factor: 8.237

Review 8.  Do Natriuretic Peptide Measurements Provide Insights into Management of End-Stage Renal Disease Patients Undergoing Dialysis?

Authors:  Thanat Chaikijurajai; Hernan Rincon Choles; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2020-09-17

9.  Biomarkers in predicting mortality and treatment in hemodialysis patients.

Authors:  Angela Yee-Moon Wang
Journal:  F1000 Med Rep       Date:  2009-03-17

10.  Angiotensin Receptor Blockades Effect on Peripheral Muscular and Central Aortic Arterial Stiffness: A Meta-Analysis of Randomized Controlled Trials and Systematic Review.

Authors:  Chih-Hsuan Yen; Yau-Huei Lai; Chung-Lieh Hung; Ping-Ying Lee; Jen-Yuan Kuo; Hung-I Yeh; Charles Jia-Yin Hou; Kuo-Liong Chien
Journal:  Acta Cardiol Sin       Date:  2014-03       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.